Clin Mol Hepatol.  2012 Dec;18(4):337-346. 10.3350/cmh.2012.18.4.337.

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension

Affiliations
  • 1Gastroenterology Research Unit, Mayo Clinic, Rochester, MN, USA. shah.vijay@mayo.edu
  • 2Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

Abstract

Because of the anatomical position and its unique vascular system, the liver is susceptible to the exposure to the microbial products from the gut. Although large amount of microbes colonize in the gut, translocation of the microbes or microbial products into the liver and systemic circulation is prevented by gut epithelial barrier function and cleansing and detoxifying functions of the liver in healthy subjects. However, when the intestinal barrier function is disrupted, large amount of bacterial products can enter into the liver and systemic circulation and induce inflammation through their receptors. Nowadays, there have been various reports suggesting the role of gut flora and bacterial translocation in the pathogenesis of chronic liver disease and portal hypertension. This review summarizes the current knowledge about bacterial translocation and its contribution to the pathogenesis of chronic liver diseases and portal hypertension.

Keyword

Leaky gut; Bacterial translocation; Lipopolysaccharide; Toll-like receptor; Kupffer cell

MeSH Terms

Antigens, CD14/metabolism
Bacterial Translocation
Gastrointestinal Tract/*microbiology
Humans
Hypertension, Portal/metabolism/*pathology
Liver/metabolism/*microbiology
Liver Cirrhosis/metabolism/*pathology
Receptors, Cytoplasmic and Nuclear/metabolism
Toll-Like Receptors/metabolism
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr